KRAS and neoplasm: The authors also confirmed that TGF-β signaling contributed to the bypass of the KRAS pathway by promoting the Epithelial-Mesenchymal transition, and the activation of RTK-PI3K-AKT signaling was another potential pathway for promoting tumor cell growth.